ArticleMolecular and clinical oncology2022

Recurrent malignant melanoma of the uterine cervix treated with anti-PD-1 antibodies and anti-CTLA-4 antibodies: A case report.

Kenbun Sone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.